Search results
Promising trial data for Moderna-Merck skin cancer vaccine sends stock rising
Quartz· 1 day agoModerna stock jumped nearly 4% on Tuesday after the the company announced positive data from an...
Study shows new cancer vaccine to treat melanoma has 96% survival rate
UNILAD· 14 hours agoA new vaccine treatment for skin cancer melanoma has shown extremely promising results in a new...
Promising Trial Results Show New Standards In Cancer Treatment And Diagnostics Are On The Horizon
Benzinga via Yahoo Finance· 13 hours agoOn Monday, Moderna (NASDAQ: MRNA) and Merck & Co (NYSE: MRK) also reported durable efficiency of...
Moderna, Merck say vaccine improved survival in patients with deadly skin cancer
CNBC· 2 days agoModerna and Merck released more positive three-year data Monday on their experimental vaccine, given...
US FDA approves Moderna's RSV vaccine with lower-than-expected efficacy in its label
Reuters· 4 days ago, opens new tab respiratory syncytial virus (RSV) vaccine, the company announced on Friday, giving...
ASCO: After Keytruda, Merck builds 3-pronged cancer strategy starring Moderna-partnered vaccine
FierceBiotech· 2 days agoAs Keytruda’s 2028 patent cliff looms large, Merck & Co.’s renewed R&D oncology strategy focuses on...
An mRNA Melanoma Vaccine Shows Promise
Time Magazine· 2 days agoIn the study, Moderna and Merck combined their cancer treatments—Moderna’s experimental cancer vaccine and Merck’s approved checkpoint ...
Moderna-Merck skin cancer vaccine shows survival benefit in long-term follow-up
Reuters via AOL· 2 days agoDetailed data on Monday from the 157-patient trial showed that after two and a half years, melanoma...
Moderna, Merck shares rise as combined melanoma therapy shows improved survival rate By...
Investing.com· 2 days agoThe vaccine, a critical component of Moderna’s pipeline, has bolstered investor confidence following...
US approves Moderna's RSV vaccine for older adults
Medical Xpress· 5 days agoThe US Food and Drug Administration on Friday approved Moderna's respiratory syncytial virus (RSV) vaccine for older adults—marking the first time any...